海外の治験の状況「多発性骨髄腫」での検索結果
205件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Thromboprophylaxis in Multiple Myeloma (TiMM)
- Multiple myeloma br>MedDRA version: 18.1 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 MedDRA version: 18.1 Level: LLT Classification code 10049909 Term: Venous thromboembolism prophylaxis System Organ Class: 100000004865 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- United Kingdom
- 2015-11-11
Authorised
- MUK nine b: OPTIMUM. A phase II study evaluating multiple novel agents in newly diagnosed high risk multiple myeloma and plasma cell leukaemia.
- Newly diagnosed high risk multiple myeloma;Therapeutic area: Diseases [C] - Cancer [C04]
- United Kingdom
- 2017-02-07
Authorised
- Duration of bisphophonate treatment in multiple myeloma
- Multiple Myeloma. br>MedDRA version: 18.1 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Denmark, Norway, Sweden
- 2014-10-14
Authorised
- Phase I/II study evaluating AUTO2 in patients with multiple myeloma
- Relapsed or Refractory Multiple Myeloma br>MedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 MedDRA version: 16.1 Level: HLT Classification code 10028229 Term: Multiple myelomas System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Netherlands, United Kingdom, United States
- 2016-10-25
Authorised
- A study in Patients with Previously Treated Multiple Myeloma
- Previously Treated Multiple Myeloma br>MedDRA version: 14.1 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Brazil, Canada, Germany, Greece, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Spain, Taiwan, Turkey, United Kingdom, United States
- 2012-04-02
Authorised
- A Study of Cobimetinib Administered as Single Agent and in Combination with Venetoclax, with or Without Atezolizumab, in Patients with Relapsed and Refractory Multiple Myeloma
- Multiple Myeloma (MM) MedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland, Spain, Sweden
- 2017-08-29
Authorised
- A Study of Cobimetinib Administered as Single Agent and in Combination with Venetoclax, with or Without Atezolizumab, in Patients with Relapsed and Refractory Multiple Myeloma
- Multiple Myeloma (MM) MedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Czech Republic, Denmark, France, Germany, Netherlands, Poland, Spain, Sweden
- 2017-08-24
Authorised
- Efficacy of vitamin D supplementation in multiple myeloma patients.
- Hypovitaminosis D;Therapeutic area: Body processes [G] - Cell Physiological Phenomena [G04]
- Netherlands
- 2018-05-14
Authorised
- Daratumumab in combination with ATRA in patients with relapsed/ refractory multiple myeloma
- relapsed/refractory multiple myeloma br>MedDRA version: 16.1 Level: HLT Classification code 10028229 Term: Multiple myelomas System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Denmark, Netherlands
- 2016-01-19
Authorised
- The effect of high dose Simvastatine on Multiple Myeloma
- Multiple Myeloma
- Denmark
- 2005-11-09
